Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01030484 |
Recruitment Status :
Completed
First Posted : December 11, 2009
Last Update Posted : February 23, 2022
|
Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Johns Hopkins Bloomberg School of Public Health
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date | December 10, 2009 | |||
First Posted Date | December 11, 2009 | |||
Last Update Posted Date | February 23, 2022 | |||
Actual Study Start Date | December 2, 2009 | |||
Actual Primary Completion Date | May 31, 2020 (Final data collection date for primary outcome measure) | |||
Current Primary Outcome Measures |
Liver histology scores [ Time Frame: varies ] Liver histology scores (derived from central reading of liver biopsy at entry, standard of care biopsy done during screening or follow-up, or liver biopsy obtained for PIVENS or TONIC trials)
|
|||
Original Primary Outcome Measures | Not Provided | |||
Change History | ||||
Current Secondary Outcome Measures | Not Provided | |||
Original Secondary Outcome Measures | Not Provided | |||
Current Other Pre-specified Outcome Measures | Not Provided | |||
Original Other Pre-specified Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title | Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2 | |||
Official Title | Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2 | |||
Brief Summary | The NAFLD Database 2 will recruit at least 1,500 new adult participants suspected or known to have NAFLD or nonalcoholic steatohepatitis (NASH)-related cirrhosis and will also invite adult participants from the prior NAFLD Database and related studies (PIVENS trial and TONIC trial) to enroll in the NAFLD Database 2. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications. | |||
Detailed Description | To add to the existing NAFLD Database an additional 1,500 adult participants with a diagnosis of NAFLD, supported by a recent liver biopsy, with a broad range of severity. Core data collection will include clinical, demographic, laboratory, imaging, and histological features
|
|||
Study Type | Observational | |||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
|||
Target Follow-Up Duration | Not Provided | |||
Biospecimen | Retention: Samples With DNA Description: plasma, serum, liver tissue
|
|||
Sampling Method | Non-Probability Sample | |||
Study Population | adult patients with suspected or known non-alcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH)-related cirrhosis of the liver | |||
Condition | Liver Disease | |||
Intervention | Not Provided | |||
Study Groups/Cohorts | NAFLD
adult patients with non-alcoholic fatty liver disease (NAFLD).
|
|||
Publications * |
|
|||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status | Completed | |||
Actual Enrollment |
2501 | |||
Original Estimated Enrollment |
1600 | |||
Actual Study Completion Date | May 31, 2020 | |||
Actual Primary Completion Date | May 31, 2020 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria | Inclusion Criteria: Continuing participants:
New participants:
Exclusion Criteria:
|
|||
Sex/Gender |
|
|||
Ages | 18 Years and older (Adult, Older Adult) | |||
Accepts Healthy Volunteers | No | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | United States | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number | NCT01030484 | |||
Other Study ID Numbers | NAFLD Adult Database 2 (IND) U01DK061730 ( U.S. NIH Grant/Contract ) |
|||
Has Data Monitoring Committee | Yes | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement | Not Provided | |||
Current Responsible Party | Johns Hopkins Bloomberg School of Public Health | |||
Original Responsible Party | Patricia Robuck, NIDDK | |||
Current Study Sponsor | Johns Hopkins Bloomberg School of Public Health | |||
Original Study Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||
Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||
Investigators |
|
|||
PRS Account | Johns Hopkins Bloomberg School of Public Health | |||
Verification Date | February 2022 |